BSO LLC

Form 483 issued September 2, 2020 · Lakewood, Colorado

Inspection
Aug 25, 2016 – Sep 2, 2020
Observations
2
Pages
2
FEI number
3011976853

In short: On September 2, 2020, FDA issued a Form 483 with 2 observations to BSO LLC in Lakewood, Colorado (FEI 3011976853) after an inspection that ran Aug 25, 2016 – Sep 2, 2020. The investigators were Zachary A. Bogorad and Zachary L. Stamm. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

2 of 2 observations on this 483 concern production.

Production2

Most cited: 21 CFR 211.111 (1×) · 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Time limits are not established when appropriate for the completion of each production phase to assure…

  2. 02

    There are no written procedures for production and process controls designed to assure that the drug…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at BSO LLC?

FDA listed 2 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected BSO LLC?

Zachary A. Bogorad and Zachary L. Stamm are named on this Form 483, for the inspection of Aug 25, 2016 – Sep 2, 2020. Each investigator has a profile showing what they cite most.

When was BSO LLC inspected by FDA?

The inspection ran Aug 25, 2016 – Sep 2, 2020, and the Form 483 is dated September 2, 2020.

How do I get the full Form 483 for BSO LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free